tandutinib   Click here for help

GtoPdb Ligand ID: 5695

Synonyms: CT53518 | MLN-518 | MLN518
Compound class: Synthetic organic
Comment: Tandutinib is reported as a fms-related tyrosine kinase 3 (FLT3) inhibitor, although it has almost identical IC50s for PDGRFβ and KIT [4].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 12
Topological polar surface area 79.4
Molecular weight 561.33
XLogP 4.53
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES COc1cc2c(cc1OCCCN1CCCCC1)nccc2N1CCN(CC1)C(=O)Nc1ccc(cc1)OC(C)C
Isomeric SMILES COc1cc2c(cc1OCCCN1CCCCC1)nccc2N1CCN(CC1)C(=O)Nc1ccc(cc1)OC(C)C
InChI InChI=1S/C32H43N5O4/c1-24(2)41-26-10-8-25(9-11-26)34-32(38)37-19-17-36(18-20-37)29-12-13-33-28-23-31(30(39-3)22-27(28)29)40-21-7-16-35-14-5-4-6-15-35/h8-13,22-24H,4-7,14-21H2,1-3H3,(H,34,38)
No information available.
Summary of Clinical Use Click here for help
Tandutinib has been investigated in Phase 2 clinical trials for various types of cancer. Click here to link to ClinicalTrials.gov's full list of Phase 2 tandutinib trials.